MAPT and Alzheimer disease 3: Positron emission tomography (PET) tracers developed for imaging of aggregated Aβ have more recently been complimented by the development of tau radiotracers, enabling comprehensive studies that investigate topographical changes of both tau and Aβ across different stages of the natural progression of AD3,5.